The cancer targeting potential of d-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes

Biomaterials

Volumn 35, Issue 15, 2014, Pages 4573-4588

  Mehra, Neelesh Kumar ^a   Verma, Ashwni Kumar ^b   Mishra, P R ^b   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Anticancer activity; Carbon nanotubes; Doxorubicin hydrochloride; Kaplan Meier survival; Tumor growth inhibition; Vitamin E

Indexed keywords

CARBON NANOTUBES; CELL CULTURE; MOLECULAR BIOLOGY; NANOCONJUGATES; POLYETHYLENE GLYCOLS; TUMORS; X RAY DIFFRACTION;

ANTICANCER ACTIVITIES; DOXORUBICIN HYDROCHLORIDE; KAPLAN-MEIER; TUMOR GROWTH; VITAMIN-E;

DISEASES;

D ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE; DOXORUBICIN; MACROGOL; MULTI WALLED NANOTUBE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CANCER CELL CULTURE; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STABILITY; DRUG UPTAKE; ELECTRON MICROSCOPY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RAMAN SPECTROMETRY; X RAY DIFFRACTION;

MUS;

ANTICANCER ACTIVITY; CARBON NANOTUBES; DOXORUBICIN HYDROCHLORIDE; KAPLAN-MEIER SURVIVAL; TUMOR GROWTH INHIBITION; VITAMIN E;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICE, INBRED BALB C; NANOTUBES, CARBON; NEOPLASMS; POLYETHYLENE GLYCOLS; VITAMIN E;

EID: 84896055295     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.022     Document Type: Article

References (48)

1. Yoong Sl, Wong B.S., Zhou Q.L., Chin C.F., Li J., Venkatesan T., et al. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum (IV) prodrug of cisplatin. Biomaterials 2014, 35:748-759.
2. Mehra N.K., Mishra V., Jain N.K. Areview of ligand tethered surface engineered carbon nanotubes. Biomaterials 2013, 35(4):1267-1283.
3. Mulvey J.J., Villa C.H., McDevitt M.R., Escorcia F.E., Casey E., Scheinberg D.A. Self-assembly of carbon nanotubes and antibodies on tumors for targeted amplified delivery. Nat Nanotechnol 2013, 8:763-771.
4. Mehra N.K., Jain A.K., Lodhi N., Dubey V., Mishra D.K., Raj R., et al. Challenges in the use of carbon nanotubes for biomedical applications. Crit Rev Ther Drug Carrier Syst 2008, 25(2):169-220.
5. Gupta R., Mehra N.K., Jain N.K. Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage. Pharm Res 2013, 10.1007/s11095-013-1162-9.
6. Mehra N.K., Mishra V., Jain N.K. Receptor-based targeting of therapeutics. Ther Deliv 2013, 4(3):369-394.
7. Hashida Y., Tanaka H., Zhou S., Kawakami S., Yamashita F., Murakami T., et al. Photothermal ablation of tumor cells using a single-walled carbon nanotubes-peptide composite. JControl Release 2014, 173:59-66.
8. Bhatnagar I., Venkatesan J., Se-Kwon K. Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells. JBiomed Nanotechnol 2014, 10(1):120-130.
9. Lodhi N., Mehra N.K., Jain N.K. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. JDrug Target 2013, 21(1):67-76.
10. Iverson N.M., Barone P.W., Shandell M., Trudel L.J., Sen S., Sen F., et al. Invivo biosensing via tissue-localizable near-infrared-fluorescent single-walled carbon nanotubes. Nat Nanotechnol 2013, 8:873-880.
11. Wu L., Man C., Wang H., Lu X., Ma Q., Cai Y., et al. PEGylated multiwalled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pham Res 2013, 30:412-423.
12. Pruthi J., Mehra N.K., Jain N.K. Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes. JDrug Target 2012, 20(7):593-604.
13. Cao N., Feng S.S. Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, invitro and invivo evaluation. Biomaterials 2008, 29:3856-3865.
14. Mehra N.K., Jain N.K. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. JDrug Target 2013, 21(8):745-758.
15. Ji Z., Lin G., Lu Q., Meng L., Shen X., Dong L., et al. Targeted therapy of SMMC-7721 liver cancer invitro and invivo with carbon nanotubes based drug delivery systems. JColloid Interface Sci 2012, 365:143-149.
16. Chopdey P.K., Tekade R.K., Mehra N.K., Mody N., Jain N.K. Glycyrrhizin conjugated dendrimer and multi-walled carbon nanotubes for liver specific delivery of doxorubicin. JNano Nanotechnol 2014, 14:1-13.
17. Singh R., Mehra N.K., Jain V., Jain N.K. Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells. JDrug Target 2013, 21(6):581-592.
18. 2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011, 32:4058-4066.
19. Muthu M.S., Kulkarni S.A., Xiong J., Feng S.S. Vitamin E TPGS coated liposome enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011, 421:332-340.
20. Gajbhiye V., Jain N.K. The treatment of glioblastoma xenografts by surfactant conjugated dendritic nano-conjugates. Biomaterials 2011, 32:6213-6225.
21. Jain A., Jain K., Mehra N.K., Jain N.K. Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells. JNanopart Res 2013, 10.1007/s11051-013-2003-9.
22. Jain A.K., Dubey V., Mehra N.K., Lodhi N., Nahar M., Mishra D.K., et al. Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomed Nanotech Biol Med 2009, 5(4):432-442.
23. Zhang Z., Lee S.H., Feng S.S. Folate-decorated poly(lactic-co-glycolide)-vitamin ETPGS nanoparticles for targeted drug delivery. Biomaterials 2007, 28(10):1889-1899.
24. Fan J., Zeng F., Xu J., Wu S. Targeted anti-cancer prodrug based on carbon nanotubes with photodynamic therapeutic effect and pH-triggered drug release. JNanopart Res 2013, 15:1911. (1-15).
25. World Health Organization (WHO) WHO technical report series, 953 2009, [accessed 25.08.13]. http://www.who.int/medicines/areas/quality_safety/quality_assurance/regulatory_standards/en/.
26. Das M., Datir S.R., Singh R.P., Jain S. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicines based on fluorescent and radiolabeled, methotrexate-folic acid-multi walled carbon nanotubes conjugate. Mol Pharm 2013, 10:2543-2557.
27. Das M., Datir S.R., Singh R.P., Jain S. Surface chemistry dependent switch regulated the trafficking and therapeutic performance of drug-loaded carbon nanotubes. Bioconjug Chem 2013, 24:626-639.
28. Jain V., Swarnakar N.K., Mishra P.R., Verma A., Kaul A., Mishra A.K., et al. Paclitaxel loaded PEGylated glyceryl monoleate based nanoparticulate carriers in chemotherapy. Biomaterials 2012, 33(29):7206-7220.
29. Wang J., Sun P., Bao Y., Liu J., An L. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol InVitro 2011, 25:242-250.
30. Ren J., Shen S., Wang D., Xi Z., Guo L., Pang Z., et al. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidised multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 2012, 33:3324-3333.
31. Agrawal A., Gupta U., Asthana A., Jain N.K. Dextran conjugated dendrite nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009, 30:3588-3596.
32. Allard-Vannier E., Cohen-Jonathan S., Gautier J., Herve-Aubert K., Munnier E., Souce M., et al. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness invitro and invivo. Eur J Pharm Biopharm 2012, 81:498-505.
33. Vrignaud S., Anton N., Gayet P., Benoit J.P., Saulnier P. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm 2011, 79:197-204.
34. Datir S.R., Das M., Singh R.P., Jain S. Hyaluronate tethered smart multi walled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem 2011, 23(11):2201-2213.
35. Mao H., Kawazoe N., Chen G. Uptake and intracellular distribution of collagen-functionalized single walled carbon nanotubes. Biomaterials 2013, 34:2472-2479.
36. Lu Y.J., Wei K.C., Ma C.C.M., Yang S.Y., Chen J.P. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surf B Biointerfaces 2012, 89:1-9.
37. Heister E., Neves V., Lamprecht C., Silva S.R.P., Coley H.M., McFadden J. Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes. Carbon 2012, 50:622-632.
38. Yudianti R., Onggo H., Sudiraman Y., Saito T., Azuma J. Analysis of functional group sited on multi-wall carbon nanotubes. Open Mater Sci 2011, 5:242-247.
39. Datsyuk V., Kalyuva M., Papagelis K., Parthenios J., Tasis D., Siokou A., et al. Chemical oxidation of multi walled carbon nanotubes. Carbon 2008, 46(6):833-840.
40. Jain A., Mehra N.K., Nahar M., Jain N.K. Topical delivery of enoxaparin using nanostructured lipid carrier. JMicroencapsul 2013, 30(7):709-715. 10.3109/02652048.2013.778908.
41. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1(1):50-56.
42. Niu L., Meng L., Lu Q. Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of doxorubicin to cancer cells. Macromol Biosci 2013, 13:735-744.
43. Gu Y.J., Cheng J., Jin J., Cheng S.H., Wong W.T. Development and evaluation of pH-responsive single-walled carbon nanotubes-doxorubicin complexes in cancer cells. Int J Nanomed 2011, 6:2889-2898.
44. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol 2001, 3(3):67-70.
45. Tounekti O., Belehradek J., Mir L.M. Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 1995, 217:506-516.
46. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for invivo cancer treatment. Cancer Res 2008, 68(16):6652-6660.
47. Al-Jamal K.T., Nunes A., Methven L., Ali-Boucetta H., Li S., Tona F.M., et al. Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile. Angew Chem Int Ed 2012, 51:6389-6393.
48. Jain S., Thakare V.S., Das M., Godugu C., Jain A.K., Mathur R., et al. Toxicity of multi walled carbon nanotubes with end defects critically depends on their functionalization density. Chem Res Toxicol 2011, 24(11):2028-2040.